SEC Form 4 · accession 0001127602-18-001398
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hooman Hakami
Officer — EVP & Group President Diabetes
Period of report
Jan 5, 2018
Accepted (ET)
Jan 8, 2018 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 5, 2018 | M | 26,158 | $62.76 | A | 91,986 | D | |
| Ordinary Shares | Jan 5, 2018 | S | 26,158 | $85.00 | D | 65,828 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F4,F5 | $62.76 | Jan 5, 2018 | M | 26,158 | D | — | Jul 28, 2024 | Ordinary Shares | 26,158 | 26,159 | D |
Explanation of responses
- F1This balance increased by 356 shares due to exempt transactions such as dividend reinvestment.
- F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F3This option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F4This option to purchase 29,743 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 29,743 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F5This option to purchase 73,296 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 73,296 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.